secwatch / observer

Lifeloc Technologies, Inc — fact timeline

Source-grounded facts extracted from Lifeloc Technologies, Inc's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.

LCTC Lifeloc Technologies, Inc JSON
Shareholder Votes

Lifeloc Technologies, Inc shareholders approved Approve the Amended and Restated Articles of Incorporation at the 2026-06-03 meeting.

“Stockholders voted to approve the Amended and Restated Articles of Incorporation. Number of Shares For Number of Shares Against Number of Shares Abstaining Broker Non-Votes 2,210,827 1,963 0 62,812”
Shareholder Votes

Lifeloc Technologies, Inc shareholders approved Advisory vote on the compensation of named executive officers (say-on-pay) at the 2026-06-03 meeting.

“Stockholders voted, by advisory vote, on the compensation of named executive officers (say-on-pay). Number of Shares For Number of Shares Against Number of Shares Abstaining Broker Non-Votes 2,209,786 3,004 0 62,812”
Shareholder Votes

Lifeloc Technologies, Inc shareholders approved Ratify the appointment of Assure CPA as its independent registered public accountant for fiscal year 2026 at the 2026-06-03 meeting.

“Stockholders voted to ratify the appointment of Assure CPA as its independent registered public accountant for fiscal year 2026 as set forth below. Number of Shares For Number of Shares Against Number of Shares Abstaining Broker Non-Votes 2,274,325 1,277 0 0”
Shareholder Votes

Lifeloc Technologies, Inc shareholders approved Elect five individuals to the Board of Directors at the 2026-06-03 meeting.

“Lifeloc stockholders voted to elect five individuals to the Board of Directors for the succeeding year as set forth below. Name Number of Shares For Number of Shares Withheld Number of Shares Abstaining Broker Non-Votes Wayne R. Willkomm, Ph.D. 2,246,607 13,681 0 15,314 Vern D. Kornelsen 2,246,607 13,681 0 15,314 Donald E. Siecke 2,246,607 13,681 0 15,314 Michael J. Kornelsen, D.M.A. 2,246,607 13,681 0 15,314 Adam Kashenberg 2,246,607 13,681 0 15,314”
Auditor Changes

Assure CPA, LLC resigned as auditor of Lifeloc Technologies, Inc.

“On June 3, 2026, Assure CPA, LLC ("Assure") notified Lifeloc Technologies, Inc. (the "Company") that it was resigning, effective June 3, 2026, as the Company's independent registered public accounting firm. Assure's resignation resulted from the sale of substantially all of Assure's assets to Sadler, Gibb & Associates, LLC ("Sadler Gibb") and Assure's cessation of operations as a public accounting firm. The professionals who served the Company at Assure have continued in their roles at Sadler Gibb. Assure's audit reports on the Company's financial statements for the fiscal years ended December 31, 2025 and December 31, 2024 did not contain an adverse opinion or a disclaimer of opinion and were not qualified or modified as to uncertainty, audit scope, or accounting principles. The resignation was not the result of any action by, or recommendation or approval of, the Company's board of directors or audit committee; it arose solely from the transaction described above. The Company's audit”
Debt Financings

Lifeloc Technologies, Inc incurred loan of $500,000 with Vern Kornelsen at 10.5% per annum (subject to upward adjustment based on changes in the prime rate maturing December 31, 2031.

“On May 4, 2026, Lifeloc Technologies, Inc. (the “Company”) entered into a loan transaction with Vern Kornelsen, the Company’s Chief Financial Officer and Chairman of the Board. The transaction consists of a Promissory Note dated May 1, 2026 (the “Note”) in the principal amount of $500,000.”
Earnings Releases

Lifeloc Technologies, Inc reported year ended December 31, 2025 results: revenue $9.027 million, net income ($2.470) million, EPS ($0.90) per diluted share.

“devices, has announced financial results for the 2025 fiscal year ended December 31, 2025. 2025 Financial Highlights Lifeloc Technologies reported revenue growth of 6% to $9.027 million for 2025, compared to net revenue of $8.538 million for 2024. We realized a net loss of ($2.470) million , or ($0.90) per diluted share for the year ending December 31, 2025”

Adam Kashenberg was appointed as Director at Lifeloc Technologies, Inc.

“On July 23, 2024, in accordance with the Company’s Amended and Restated Bylaws (the “Bylaws”), the Board appointed Adam Kashenberg to fill the vacancy on the Board and on the Company’s audit committee created by Mr. Greenlee’s resignation.”

Robert Greenlee resigned as Director at Lifeloc Technologies, Inc.

“On July 22, 2024, Robert Greenlee notified the Company by letter of his resignation from the board of directors (the “Board”) of the Company.”
Earnings Releases

Lifeloc Technologies, Inc reported first quarter ended March 31, 2024 results: revenue $2.153 million, net income $(284) thousand, EPS $(0.12) per diluted share.

“Lifeloc posted quarterly net revenue of $2.153 million resulting in a quarterly net loss of $(284) thousand, or $(0.12) per diluted share.”
Earnings Releases

Lifeloc Technologies, Inc reported fiscal year ended December 31, 2023 results: revenue $9.330 million, net income $206 thousand, EPS $0.08 per diluted share.

“Lifeloc Technologies posted annual net revenue of $9.330 million resulting in a net profit of $206 thousand in 2023, or $0.08 per diluted share.”
Earnings Releases

Lifeloc Technologies, Inc reported third quarter ended September 30, 2023 results: revenue $2.696 million, net income $110 thousand, EPS $0.04 per diluted share.

“Lifeloc posted quarterly net revenue of $2.696 million in the third quarter of 2023, resulting in a quarterly net profit of $110 thousand, or $0.04 per diluted share.”
Auditor Changes

Lifeloc Technologies, Inc engaged GreenGrowth CPAs as its auditor.

“On October 17, 2023, the Company engaged and executed an agreement with GreenGrowth, effective immediately, as the Company’s new independent accountant to replace Gries.”
Auditor Changes

Gries & Associates, LLC resigned as auditor of Lifeloc Technologies, Inc.

“Resignation of Registrant’s Certifying Accountant On October 2, 2023, the Company was informed that Gries & Associates, LLC (“Gries”) had sold its business to GreenGrowth CPAs (“GreenGrowth”) and was therefore resigning.”
Auditor Changes

Lifeloc Technologies, Inc engaged GreenGrowth CPAs as its auditor.

“On October 17, 2023, the Company engaged and executed an agreement with GreenGrowth CPAs ("GreenGrowth"), as the Company’s new independent accountant to replace Gries.”
Earnings Releases

Lifeloc Technologies, Inc reported the quarter ended June 30, 2023 results: revenue $2.280 million, net income $55 thousand, EPS $0.02 per diluted share.

“Lifeloc posted quarterly net revenue of $2.280 million in the second quarter of 2023, resulting in a quarterly net profit of $55 thousand, or $0.02 per diluted share.”
Shareholder Votes

Lifeloc Technologies, Inc shareholders approved Advisory vote on frequency of future say-on-pay votes at the 2023-05-17 meeting.

“Stockholders voted to ratify approve, on an advisory basis, on the frequency of future “Say on Pay” as set forth below. Every One Year Every Two Years Every Three Years 32,414 1,572 1,858,607”
Shareholder Votes

Lifeloc Technologies, Inc shareholders approved Advisory vote to approve compensation of named executive officers at the 2023-05-17 meeting.

“Stockholders voted to ratify approve, on an advisory basis, the compensation of our named executive officers as set forth below. Number of Shares Against Number Non-Votes 1,858,607 32,414 1,572 0”
Shareholder Votes

Lifeloc Technologies, Inc shareholders approved Ratification of appointment of Gries & Associates LLC as independent registered public accountant for fiscal year 2023 at the 2023-05-17 meeting.

“Stockholders voted to ratify the appointment of Gries & Associates LLC as its independent registered public account for fiscal year 2023 as set forth below. Number of Shares Against Number Non-Votes 1,916,731 0 0 0”
Shareholder Votes

Lifeloc Technologies, Inc shareholders approved Election of five directors to the Board at the 2023-05-17 meeting.

“Lifeloc Technologies, Inc., a Colorado corporation (“Lifeloc” or the “Company”) held its Annual Meeting of Shareholders on May 17, 2023 (the “Annual Meeting”). As of the record date of the Annual Meeting, there were 2,454,116 shares of Common Stock issued and outstanding and entitled to vote at the Annual Meeting. The following matters were submitted and voted upon at the Annual Meeting: 1. Lifeloc stockholders voted to elect five individuals to the Board of Directors for the succeeding year as set forth below. Name Number of Shares Withheld Number Non-Votes Wayne Willkomm, Ph.D. 1,895,167 0 2,329 0 Vern D. Kornelsen 1,895,167 0 2,329 0 Robert Greenlee 1,895,167 0 2,329 0 Donald E. Siecke 1,895,167 0 2,329 0 Michael J. Kornelsen, D.M.A. 1,895,167 0 2,329 0”
Earnings Releases

Lifeloc Technologies, Inc reported first quarter ended March 31, 2023 results: revenue $2.165 million, net income $(54) thousand, EPS $(0.02) per diluted share.

“Lifeloc posted quarterly net revenue of $2.165 million resulting in a quarterly net loss of $(54) thousand, or $(0.02) per diluted share.”
Earnings Releases

Lifeloc Technologies, Inc reported the nine months ended September 30, 2022 results: revenue $6.373 million, net income $(433) thousand, EPS $(0.18) per diluted share.

“Nine-month net revenue of $6.373 million and a net loss of $(433) thousand, or $(0.18) per diluted share, compared to net revenue of $5.427 million and a net profit of $816 thousand, or $0.33 per diluted share, for the same nine months of 2021.”
Earnings Releases

Lifeloc Technologies, Inc reported the quarter ended September 30, 2022 results: revenue $2.032 million, net income $(87) thousand, EPS $(0.04) per diluted share.

“Lifeloc posted quarterly net revenue of $2.032 million in the third quarter of 2022, resulting in a quarterly net loss of $(87) thousand, or $(0.04) per diluted share.”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.